NOVARTIS N (NOVN.SW)

Healthcare

$119.10

+1.17%

nightly snapshot · 10/11/2026

ALPHASCORE™ · B+ · Buy

ALPHASCORE

70

/ 100

B+

BUY

▲ 0 · 30D

KEY FUNDAMENTALS

P/E22.7

ROE30.4%

NET MARGIN24.7%

GROSS MARGIN75.8%

MKT CAP$226.38B

loading full analysis…

DAILY BRIEF

Novartis N secures an AlphaScore of 70/100 in the healthcare sector. The snapshot dated October 11, 2026, details a return on equity of 30.35% and a net margin of 24.67%. A major strength is its exceptionally high gross margin of 75.83%, pointing to strong pricing power. A relative risk is evident in its debt-to-equity ratio of 1.17, showing elevated leverage relative to equity.

Written 11/10/2026, 00:40:23 UTC · Snapshot 11/10/2026